The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of VEGFR-TKI plus immune checkpoint inhibitor (ICI) in metastatic renal cell carcinoma (mRCC) patients with favorable IMDC prognosis.
 
Chiara Ciccarese
No Relationships to Disclose
 
Roberto Iacovelli
Honoraria - IPSEN; MSD; Pfizer
Consulting or Advisory Role - Astellas Pharma; Janssen; Novartis; Pfizer; Sanofi
Speakers' Bureau - Ipsen; Janssen; Pfizer; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; Pfizer
 
Emilio Bria
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Giovanni Schinzari
No Relationships to Disclose
 
Ernesto Rossi
No Relationships to Disclose
 
Serena Astore
No Relationships to Disclose
 
Maria Antonella Cannella
No Relationships to Disclose
 
Tatiana D'Angelo
No Relationships to Disclose
 
Carlo Maria Cicala
No Relationships to Disclose
 
Maria Grazia Maratta
No Relationships to Disclose
 
Giampaolo Tortora
Consulting or Advisory Role - BMS Brazil; Novartis